Navigation path

Ebola virus

New: EU research on Ebola

To address the urgent need, the EU is boosting its investment in Ebola research via an exceptional procedure – supporting the most advanced vaccine and treatment candidates

World Cancer Day: EU Research to Fight Cancer

In 2008 (latest figures available), an estimated 2.4 million new cases of cancer, excluding non-melanoma skin cancers, were diagnosed in EU countries – 55% in men, and 45% in women. The most commonly diagnosed cancers were prostate, colorectal, breast and lung cancer. Yet it is estimated that more than one third of cancers are preventable.

Where does the EU come into the picture? To mark World Cancer Day 2013 (4 February), here is a quick look at what the EU is doing in the field of cancer research.


The EU invests over €180 million per year in cancer research.

The EU is an important cancer research funder. During the past six years, the EU has invested more than €1.1 billion in international collaborative research, frontier research, mobility programmes, public-private partnerships and coordination of national cancer research efforts.

More than half this budget – €680 million – has been used to encourage key players from across Europe and beyond to join forces in 'collaborative research projects', to find new ways to fight cancer and help patients. These projects help us better understand how various types of cancer develop, how they can be diagnosed earlier and treated more successfully.

Here are two examples of successful, EU-funded cancer research projects:

Photo of a girl with cancer

Harnessing 3D imagery for early tumour detection

More than three million people in Europe are diagnosed with some form of cancer every year, and despite the advances in science, there is still much to learn about this disease. The European Union (EU)-funded research project ENTERVISION is developing a new way of harnessing radiotherapy, using 3D digital imagery, to provide earlier tumour detection and more effective treatments.

Photo of 2 researchers giving us the thumbs up

Boosting research to defeat cancer

Despite many scientific breakthroughs over the years, cancer remains a deadly disease, and treatments are often limited in their scope. But cancer research is improving and one of the most promising areas is in biological therapy, or biotherapy, where a €100 million loan from the European Investment Bank (EIB) with financial backing from the European Union is helping find out how to manage molecules to kill cancer cells while sparing their healthy neighbours.

 

For more information:

10 Facts on EU Action to Fight Cancer

European Commission's Cancer research web site

European Commission's Public Health Cancer web site